Glaxo loses jobs, Camden gains a headquarters & sustainable offices evolve
GlaxoSmithKline’s looming job cuts Earlier this fall it became known that GlaxoSmithKline, British drugmaker, was planning a restructuring of their U.S. operations over the next three years. GSK plans to eliminate $1.57 billion in annual expenses. Details began to surface early this week (read more on njbiz.com) and fears that some of the jobs located […]